<DOC>
	<DOC>NCT00914667</DOC>
	<brief_summary>This is an open-label, randomized, two-way crossover study to evaluate the steady-state effect of fesoterodine (8 mg QD) on the pharmacodynamics and pharmacokinetics of a single supratherapeutic dose of warfarin (25 mg) in healthy subjects.</brief_summary>
	<brief_title>The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Healthy male and/or female subjects between the ages of 18 and 55 years Not healthy subjectssubjects with acute or chronic medical or psychiatric conditions or laboratory abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Overactive Bladder Urgency Frequency</keyword>
</DOC>